Action 002332 ZHEJIANG XIANJU PHARMACEUTICAL CO.,LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Zhejiang Xianju Pharmaceutical Co.,Ltd.

Actions

002332

CNE100000K64

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 17/05/2024 		Varia. 5j. Varia. 1 janv.
12,63 CNY +1,77% Graphique intraday de Zhejiang Xianju Pharmaceutical Co.,Ltd. +2,68% -1,10%
24/04 Zhejiang Xianju Pharmaceutical Co. publie ses résultats pour le premier trimestre clos le 31 mars 2024 CI
2023 Xianju Pharma va investir 33 millions de yuans dans une entreprise locale de recherche et développement de médicaments MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Zhejiang Xianju Pharmaceutical Co.,Ltd. Proposes Final Dividend for the Year 2023
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Xianju Pharma to Invest 33 Million Yuan in Local Drug R&D Firm
Hangzhou Yuhong Pharmaceutical Technology Co., Ltd. announced that it expects to receive CNY 80 million in funding from Zhejiang Xianju Pharmaceutical Co.,Ltd., Jiaxing Miyin Yuhong Equity Investment Partnership Enterprise (L.P.), Hainan Huishengde Enterprise Management Partnership Enterprise (L.P.), Hangzhou Yulin Enterprise Management Partnership Enterprise (L.P.)
Zhejiang Xianju Pharmaceutical's Flumazenil Injection Chosen for China's Centralized Bid
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Zhejiang Xianju Pharmaceutical Co.,Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 02 June 2023
Zhejiang Xianju Pharmaceutical Co.,Ltd. Approves Cash Dividend for the Year 2022
Zhejiang Xianju Pharmaceutical Co.,Ltd. Proposes Final Dividend for 2022
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Zhejiang Xianju Pharma’s Abortion Tablet Passes Consistency Evaluation
Zhejiang Xianju Pharma Logs 20.4% Jump in 2022 Profit
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Ningbo Linghan Enterprise Management Partnership Enterprise (Limited Partnership) entered into equity transaction contract to acquire 14.60% stake in Hangzhou Weisibo Medical Technology Co., Ltd. from Zhejiang Xianju Pharmaceutical Co.,Ltd. for CNY 8 million.
Zhejiang Xianju Pharmaceutical Co.,Ltd. Approves Management Elections
Zhejiang Xianju Pharmaceutical Co.,Ltd.(SZSE:002332) dropped from Shenzhen Stock Exchange Component A Share Index
Zhejiang Xianju Pharmaceutical Co.,Ltd.(SZSE:002332) dropped from Shenzhen Stock Exchange Component Index
Zhejiang Xianju Pharmaceutical Receives Regulatory Approval for Injection
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 002332
  4. Actualités Zhejiang Xianju Pharmaceutical Co.,Ltd.
  5. Autres langues